Sarah’s Journey With ALK+ Metastatic NSCLC

Opinion
Video

A 55-year-old mom and high school teacher who received lorlatinib for ALK+ NSCLC with brain metastases.

Recent Videos
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content